Prelude Therapeutics
PRLD
#9213
Rank
โ‚ฌ65.62 M
Marketcap
1,19ย โ‚ฌ
Share price
-4.62%
Change (1 day)
-68.55%
Change (1 year)

EPS for Prelude Therapeutics (PRLD)

EPS in 2023 (TTM): -2,01ย โ‚ฌ

According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -2,09ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,35ย โ‚ฌ a decrease over its 2021 EPS that were of -2,33ย โ‚ฌ.

EPS history for Prelude Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,01ย โ‚ฌ-14.2%
2022-2,35ย โ‚ฌ0.83%
2021-2,33ย โ‚ฌ-61.3%
2020-6,01ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-2,10ย โ‚ฌ 0.46%๐Ÿ‡บ๐Ÿ‡ธ USA